Prevalence of Alpha and Beta-Thalassemia Mutations Among Carriers of Thalassemia in Shadegan City, Southwest of Iran

Authors Information
Article Notes and Dates
To Cite : Doosti Irani A, Cheraghi Z, Bitaraf S, Cheraghi P, Safiri S. et al. Prevalence of Alpha and Beta-Thalassemia Mutations Among Carriers of Thalassemia in Shadegan City, Southwest of Iran, Zahedan J Res Med Sci. 2015 ;17(8):e1032. doi: 10.17795/zjrms1032.
Abstract
1. Introduction
2. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. 2001; [DOI]
  • 2. Hosseini GL. Hemoglobin in health and disease. 2005;
  • 3. Habibzadeh F, Yadollahi M, Haghshenas M. Epidemiology and control of common disease in Iran. 2011;
  • 4. Merat A, Haghshenas M, Pour ZM, Plonczynski MW, Harrell AN, Coleman MB, et al. Beta-thalassemia in southwestern Iran. Hemoglobin. 1993; 17(5): 427-37[PubMed]
  • 5. Akhavan-Niaki H, Derakhshandeh-Peykar P, Banihashemi A, Mostafazadeh A, Asghari B, Ahmadifard MR, et al. A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis. 2011; 47(1): 29-32[DOI][PubMed]
  • 6. Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran. Hemoglobin. 2007; 31(3): 343-9[DOI][PubMed]
  • 7. Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian beta-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica. 2002; 87(10): 1113-4[PubMed]
  • 8. Rahimi Z, Muniz A, Akramipour R, Tofieghzadeh F, Mozafari H, Vaisi-Raygani A, et al. Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol Dis. 2009; 42(2): 140-3[DOI][PubMed]
  • 9. Comprehensive national program guidelines and instructional texts prevention of beta-thalassemia. 2004;
  • 10. Greer JP, Foerster J, Rodgers GM. Wintrobes clinical hematology. 2009;
  • 11. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989; 17(7): 2503-16[PubMed]
  • 12. Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tayapiwatana C, Kasinrerk W, Tongsong T. Accuracy of immunochromatographic strip test in diagnosis of alpha-thalassemia-1 carrier. J Med Assoc Thai. 2011; 94(7): 761-5[PubMed]
  • 13. Neishabury M, Azarkeivan A, Najmabadi H. Frequency of positive XmnIGgamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation. Blood Cells Mol Dis. 2010; 44(2): 95-9[DOI][PubMed]
  • 14. Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, et al. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele. Hemoglobin. 2002; 26(2): 147-54[PubMed]
  • 15. Behfar M, Ehsani MA, Salamati P, et al . Associations of red blood corpuscle mean volume and hematocrit with severity of beta-globin gene mutations in beta-thalassemia carriers. Sci J School Public Health Institute Public Health Res. 2011; 8(4): 41-9
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Zahedan Journal of Research in Medical Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check